© 2022 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2022 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
A panel of experts along with a patient and caregiver discuss the emergence of PSMA-targeting therapy for patients with metastatic castration resistant prostate cancer (mCRPC).
June 1st 2022
An overview of metastatic castration-resistant prostate cancer (mCRPC) and the role of PSMA in mCRPC.
July 1st 2022
Jeremie Calais, MD, comments on how PSMA PET scans have changed the treatment landscape for patients with mCRPC and describes the process for obtaining a PSMA PET scan, including what patients should know before, during and after the scan.
Joseph Wood, a patient, and Deborah Wood, Joseph’s wife and caregiver, talk about Joseph’s prostate cancer diagnosis and Deborah explains her role as a caregiver.
July 13th 2022
Dr Matthew Rettig reviews the front-line treatment options for patients with metastatic castration-resistant prostate cancer (mCRPC) and what factors are considered when choosing appropriate treatment.
Dr Jeremie Calais talks about the emergence and importance of PSMA-targeted radioligand therapy.
July 26th 2022
Dr Jeremie Calais reviews the VISION trial and the implications of the data in the treatment paradigm for metastatic castration-resistant prostate cancer (mCRPC).
Joseph Wood details his treatment journey with metastatic castration-resistant prostate cancer (mCRPC) and how the journey has impacted his wife and caregiver, Deborah Wood.
August 2nd 2022
Dr Jeremie Calais shares some clinical pearls for lutetium-177 PSMA 617 and how this therapy has changed the treatment landscape for patients with metastatic castration resistant prostate cancer (mCRPC).
Drs Matthew Rettig and Jeremie Calais explain what it means to be a part of a collaborative team and how communication plays a big role in patients receiving optimal treatment.
August 8th 2022
Joseph Wood and his wife and caregiver, Deborah, share their concerns and questions about radioligand therapy and how the COVID-19 pandemic has impacted their treatment experience.
August 11th 2022
Joseph Wood and his caregiver, Deborah Wood, provide advice for patients and caregivers with prostate cancer who may be in similar situations, and comment on the support they have received from their family and community.
Trodelvy Lengthens Time to Disease Progression in Metastatic Breast Cancer
The Journey to a Healthy Lifestyle After Cancer
Getting Out of the Woods: Strategies to Cope With Fear of Cancer Recurrence
Cancer Made Me Appreciate the Small Things in Life